Imatinib Intermediate Manufacturer in India

Imatinib Intermediate Manufacturer in India – Vihita Bio

Vihita Bio is a leading Imatinib Intermediate Manufacturer in India, specializing in the production of high-quality intermediates, including 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (C₁₃H₁₈N₂O₂·2HCl), a critical component in the synthesis of imatinib mesylate. Marketed as Gleevec or Glivec, imatinib mesylate is a tyrosine kinase inhibitor used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GIST), and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). With state-of-the-art manufacturing facilities in India, Vihita Bio delivers premium C₁₃H₁₈N₂O₂·2HCl to meet the needs of the global pharmaceutical industry as of 12:22 AM PDT on Saturday, April 05, 2025. Whether you need a reliable supplier or bulk production, Vihita Bio ensures top-quality solutions tailored to your requirements.

Why Choose Vihita Bio for Imatinib Intermediate Supply?

Vihita Bio stands out as a trusted name in India for manufacturing imatinib intermediates like 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride. Here’s why we are the preferred choice:

• Advanced Production Technology: Cutting-edge equipment ensures consistent purity and quality in every batch.
• Stringent Quality Control: Rigorous testing to meet international pharmaceutical standards, including GMP compliance.
• Customized Solutions: Tailored C₁₃H₁₈N₂O₂·2HCl production to suit your specific imatinib synthesis needs.
• Timely Delivery: Efficient logistics for seamless supply chain support.

Applications of Imatinib Intermediates by Vihita Bio

Imatinib intermediates, including 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (C₁₃H₁₈N₂O₂·2HCl), are vital for the pharmaceutical industry, supporting the production of imatinib mesylate for various treatments. As a top manufacturer in India, Vihita Bio supplies these intermediates for:

• Cancer Treatment: Essential for manufacturing imatinib, used to manage CML, GIST, and Ph+ ALL.
• Pharmaceutical R&D: Supports research for developing new cancer therapies and drug formulations.
• Active Pharmaceutical Ingredient (API) Production: Key components for creating high-quality APIs.

Our intermediates ensure optimal performance in these critical applications.

Benefits of Partnering with a Top Imatinib Intermediate Producer

Choosing Vihita Bio for your imatinib intermediate needs offers distinct advantages:

• Cost-Effective Solutions: High-quality 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride at competitive prices.
• Sustainable Practices: Eco-friendly production methods to minimize environmental impact.
• Expert Technical Support: Guidance for integrating C₁₃H₁₈N₂O₂·2HCl into your pharmaceutical processes.

Our Manufacturing Process for Imatinib Intermediates

At Vihita Bio, we employ a meticulous process to produce imatinib intermediates, including 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (C₁₃H₁₈N₂O₂·2HCl). From sourcing premium raw materials to final quality checks, our facilities in India are optimized for efficiency and precision. We adhere to strict safety and regulatory standards, ensuring that every batch meets the rigorous demands of the pharmaceutical industry.

Quality Assurance from a Leading Imatinib Intermediate Maker

Quality is our cornerstone. As a leading imatinib intermediate maker in India, we implement comprehensive quality controls throughout the production of 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride. Our certifications and compliance with global standards make Vihita Bio a preferred partner for pharmaceutical companies seeking reliable intermediates for imatinib production.

Contact Vihita Bio – Your Trusted Imatinib Intermediate Partner

Ready to source premium imatinib intermediates like 4-[(4-Methylpiperazin-1-yl)methyl]benzoic acid dihydrochloride (C₁₃H₁₈N₂O₂·2HCl) from a top manufacturer in India? Vihita Bio is here to assist. Contact Us to connect with us and discuss your requirements as of 12:22 AM PDT on Saturday, April 05, 2025. For more information on imatinib and its applications, explore Wikipedia’s Imatinib Page. Whether you need bulk orders or custom formulations, we’re your go-to partner for imatinib intermediates.